Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • Resource and Technical Advances
    • Clinical Medicine
    • Reviews
    • Editorials
    • Perspectives
    • Top read articles
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Transfers
  • Advertising
  • Job board
  • Contact
Recapitulation of developmental mechanisms to revascularize the ischemic heart
Karina N. Dubé, … , Paul R. Riley, Nicola Smart
Karina N. Dubé, … , Paul R. Riley, Nicola Smart
Published November 16, 2017
Citation Information: JCI Insight. 2017;2(22):e96800. https://doi.org/10.1172/jci.insight.96800.
View: Text | PDF
Research Article Cardiology

Recapitulation of developmental mechanisms to revascularize the ischemic heart

  • Text
  • PDF
Abstract

Restoring blood flow after myocardial infarction (MI) is essential for survival of existing and newly regenerated tissue. Endogenous vascular repair processes are deployed following injury but are poorly understood. We sought to determine whether developmental mechanisms of coronary vessel formation are intrinsically reactivated in the adult mouse after MI. Using pulse-chase genetic lineage tracing, we establish that de novo vessel formation constitutes a substantial component of the neovascular response, with apparent cellular contributions from the endocardium and coronary sinus. The adult heart reverts to its former hypertrabeculated state and repeats the process of compaction, which may facilitate endocardium-derived neovascularization. The capacity for angiogenic sprouting of the coronary sinus vein, the adult derivative of the sinus venosus, may also reflect its embryonic origin. The quiescent epicardium is reactivated and, while direct cellular contribution to new vessels is minimal, it supports the directional expansion of the neovessel network toward the infarcted myocardium. Thymosin β4, a peptide with roles in vascular development, was required for endocardial compaction, epicardial vessel expansion, and smooth muscle cell recruitment. Insight into pathways that regulate endogenous vascular repair, drawing on comparisons with development, may reveal novel targets for therapeutically enhancing neovascularization.

Authors

Karina N. Dubé, Tonia M. Thomas, Sonali Munshaw, Mala Rohling, Paul R. Riley, Nicola Smart

×

Figure 2

Lineage-tracing neovascularization in the infarcted heart.

Options: View larger image (or click on image) Download as PowerPoint
Lineage-tracing neovascularization in the infarcted heart.
PdgfbCreERT2;...
PdgfbCreERT2; R26R-EYFP mice were injected with 2 doses of 2 mg tamoxifen to prelabel coronary endothelial cells, 2 weeks prior to myocardial infarction (A), and assessed before/after infarction by immunostaining. In noninfarcted mice, capillary (B and C), venous (D and E), and arterial (F and G) endothelial cells were efficiently labeled with EYFP (EYFP+ cells indicated with arrows); only the endocardium remained 100% unlabeled with the reporter (arrowheads in C). In the border zone after infarction (day 7), 73.6% ± 3.4% of capillary endothelial cells were EYFP+ (H–M; box in M enlarged in N and O; arrows indicate EYFP+ cells), thus preexisting or derived via angiogenesis from existing endothelium. However, 26.4% ± 3.4% of infarct/border zone endothelial cells were EYFP– (H–J and P), including long capillaries extending into the infarct (K–O; arrowheads indicate EYFP– ECs). EYFP– cells were Pdgfb– prior to injury and thus newly derived, either via vasculogenesis from a nonendothelial source or from the endocardium. MI, myocardial infarction; I/B, infarct/border zone; myo, myocardium; epi, epicardium; Tam, tamoxifen. Scale bars: 20 μm (B–G); 50 μm (H–M); 20 μm (N and O). n = 4 injured hearts and n = 3 uninjured hearts; quantification from 4 capillary fields, 6 arteries, and 6 veins per uninjured heart and from 4 border zone regions each from 3 sections, approximately 100 μm apart, per inured heart. Mean ± SEM; 2-tailed Student’s t test; ***P ≤ 0.001.

Copyright © 2023 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts